Peters John Sheldon sold $272K of LMND

Peters John Sheldon (Chief Insurance Officer) sold 3,444 shares of Lemonade, Inc. (LMND) at $79.00 ($0.27M total) on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Peters John Sheldon
Published Jul 9, 2026, 1:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 9, 2026, 2:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LMND
Neutral
high confidence
Mentioned
$LMND
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LMNDNeutralLow
01

Why it matters

The newest concrete fact is the specific sale size, price, and that it was executed under a pre-arranged 10b5-1 plan, which generally dampens market interpretation.

02

Market read

Traders may log the transaction for positioning and sentiment checks, but it is unlikely to drive a fundamental repricing by itself.

03

What to watch

The article provides no context on total planned sales, whether this is part of a larger tranche, or any concurrent company news, limiting inference.

Relevance 3/10Novelty 3/10Timing: new Form 4 filed 2026-07-08 for a 2026-07-06 sale

Background

The article is a SEC Form 4 insider transaction disclosure for Lemonade, Inc.

Company-level read

Ticker impact

$LMNDNeutralHigh confidence
Context

Lemonade insider Peters John Sheldon, Chief Insurance Officer, sold 3,444 shares at $79 on 2026-07-06 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale.

Evidence & confidence

The filing specifies an open-market sale and confirms a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Minimal, as the disclosure is company-specific insider trading without any operational or regulatory development.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with internal caution, so some traders may still monitor for follow-on disclosures.

Key entities

  • Lemonade, Inc.

    Subject of the Form 4 insider transaction; Chief Insurance Officer Peters John Sheldon sold shares under a 10b5-1 plan.

  • Peters John Sheldon

    Chief Insurance Officer who executed an open-market sale of 3,444 shares at $79.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LMNDMed

Lemonade stock price target lowered to $45 by Keefe Bruyette

Keefe Bruyette & Woods lowered its price target on Lemonade Inc. (NYSE:LMND) to $45 from $48, citing higher growth spending and operating expenses. The firm noted Lemonade's premium growth exceeds 30% and revenue grew nearly 70% in the last twelve months. Lemonade reported Q3 2026 earnings, exceeding expectations with revenue of $336.1 million and adjusted loss of $0.56 per share.

$LMNDMed

Lemonade Q3 Earnings Call Highlights

Lemonade (LMND) reported Q3 operating expenses rose 36% YoY, driven by higher sales and marketing, and administrative costs. Adjusted free cash flow was $27M, with $1.2B in cash. Lemonade Car's premium grew 63% YoY, and the company expects slower growth spending. Loss ratios varied by product, with pet insurance under pressure. The company plans to discuss AI initiatives at its investor day.

$LMNDHighAI 8/10

Lemonade (LMND) Q3 2026 Earnings Call Transcript

Lemonade (LMND) reported Q3 2026 results: $1.55B in-force premium (+34%), $336.1M revenue (+73%), $118.1M gross profit (+48%), and $20.4M adjusted EBITDA loss (improved from prior year). Customer base grew 23% to 3.5M, with premium per customer up 9% to $440. Gross loss ratio increased to 65% due to inflation and weather events. Management expects Q4 adjusted EBITDA to be positive and full-year revenue between $1.23B and $1.235B.

$LMNDMed

Lemonade Inc (LMND) (Q3 2026) Earnings Call Highlights: Record Premium Growth and a Clear

Lemonade Inc (LMND) reported Q3 2026 earnings, highlighting record premium growth and strategic advantages from AI agents. CEO Daniel Schreiber noted AI's potential to favor Lemonade over incumbents. CFO Tim Bixby discussed car insurance loss ratios, G&A expenses, and pet insurance trends. The company expects accelerated state rollouts and cross-sales growth, with no significant incremental customer acquisition costs for cross-sold products.